SINGAPORE > China based Yifan Pharmaceutical Co. is set to acquire 90% of Singapore based biopharmaceutical company SciGen Ltd

yigan logo China based Yifan Pharmaceutical Co. is set to acquire Singapore based biopharmaceutical company SciGen Ltd for approximately $28 million for $0.05 a share to acquire at least 90% of SciGen which is listed in the Australian Stock Exchange. The full takeover would value SciGen at $28 million. Yifan has signed an agreement with SciGen’s controlling shareholder Bioton SA that owns More …